Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy
Epilepsia · 2026
DOI: 10.1002/epi.70258 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsia, 2026. Verfasst von Mira Hamze und 19 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille University, Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale, Marseille, France. Hauptthemen laut MEDLINE: Developmental Disabilities, Epilepsy, Symporters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Agence Nationale de la Recherche, Conseil National de la Recherche Scientifique.
Abstract (Originalsprache)
Objective
This study was undertaken to characterize the functional impact of novel SLC12A5 variants in two unrelated patients with early onset developmental and epileptic encephalopathy (DEE) and to investigate the mechanisms underlying KCC2 dysfunction.
Methods
Clinical, genetic, and functional analyses were performed in two patients (Cases A and B) with DEE. SLC12A5 encodes two KCC2 splice isoforms (KCC2a and KCC2b). Functional effects of the identified variants on KCC2b ion transport, phosphorylation, mRNA processing, and KCC2‐dependent synaptogenesis were assessed using in vitro assays in heterologous expression systems and primary neurons, supported by in silico structural modeling.
Results
Both patients developed severe neonatal onset DEE characterized by developmental delay, axial hypotonia, extrapyramidal features, and bilateral migratory seizures within 24 h of birth. Both cases resulted in early mortality (Case A at 9 years; Case B at 6 months). Sequencing revealed distinct biallelic compound heterozygous SLC12A5 variants in both individuals, each inherited from one unaffected parent. Functional analyses demonstrated that in Case A, one variant markedly reduced KCC2‐mediated ion transport, whereas the second variant preserved transport activity but exhibited an altered phosphorylation profile at Ser940, located on the intracellular C ‐terminal region. This variant also disrupted wild‐type (WT) KCC2‐dependent excitatory synapse formation in immature rat hippocampal neurons. In Case B, one variant disrupted normal mRNA transcript processing consistent with loss of expression, and the second variant exhibited reduced ion transport activity. Significance These data demonstrate that SLC12A5 ‐related DEE can result from combined impairment of KCC2‐dependent chloride homeostasis and disruption of chloride‐independent KCC2 functions critical for early neuronal development. This work expands the mutational and mechanistic spectrum of SLC12A5 ‐DEE and highlights the importance of KCC2 regulatory roles in early brain development, providing new knowledge and tools for basic research and potential avenues for targeted precision therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix-Marseille University, Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale, Marseille, France.
- Division of Neurology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Department of Pediatric Neurology and Reference Center of Rare Epilepsies, University, Hospitals of Lyon, Bron, France.
- Department of Pediatric Neurology, Assistance Publique-Hôpitaux de Marseille, La Timone Children's Hospital, Marseille, France.
- Division of Neurogenetics, Faculty VI, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
- Research Center for Neurosensory Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
ORCID-Profile: Mira Hamze, Robyn Whitney, Dorothée Ville, Nathalie Villeneuve, Anna-Maria Hartmann, Lisa Becker, Jens Hausmann, Jinwei Zhang, Cathy Brier, Lucie I Pisella, Perrine Friedel, Audrey Labalme, Eudeline Alix, Nicolas Chatron, Damien Sanlaville, Sylvie Gory-Fauré, Eric Denarier, Christophe Porcher, Gaetan Lesca, Igor Medina
Förderung
- Institut National de la Santé et de la Recherche Médicale
- Agence Nationale de la Recherche
- Conseil National de la Recherche Scientifique
- French Ministry of Higher Education and Research (MRT)
- French foundation for epilepsy research (FFRE)
- Institut de Neurobiologie de la Méditerranée (INMED)
- Marseille Maladies Rares Institute (MarMaRa)
- Ministère de l'Enseignement supérieur et de la Recherche
Zitieren
APA
Hamze, M., Whitney, R., Ville, D., Villeneuve, N., Hartmann, A. M., Becker, L., Hausmann, J., Zhang, J., Brier, C., Pisella, L. I., Friedel, P., Labalme, A., Alix, E., Chatron, N., Sanlaville, D., Gory-Fauré, S., Denarier, E., Porcher, C., Lesca, G., & Medina, I. (2026). Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy. Epilepsia. https://doi.org/10.1002/epi.70258
Vancouver
Hamze M, Whitney R, Ville D, Villeneuve N, Hartmann AM, Becker L, et al. Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy. Epilepsia. 2026. doi:10.1002/epi.70258
BibTeX
@article{Hamze2026,
author = {Hamze, Mira and Whitney, Robyn and Ville, Dorothée and Villeneuve, Nathalie and Hartmann, Anna-Maria and Becker, Lisa and Hausmann, Jens and Zhang, Jinwei and Brier, Cathy and Pisella, Lucie I and Friedel, Perrine and Labalme, Audrey and Alix, Eudeline and Chatron, Nicolas and Sanlaville, Damien and Gory-Fauré, Sylvie and Denarier, Eric and Porcher, Christophe and Lesca, Gaetan and Medina, Igor},
title = {Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70258}
}
EUVIMED